Log In
BCIQ
Print this Print this
 

CZ-48

  Manage Alerts
Collapse Summary General Information
Company Cao Pharmaceuticals Inc.
DescriptionAnalog of camptothecin, a topoisomerase I (TOP1) inhibitor
Molecular Target Topoisomerase I (TOP1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
PartnerNanoMaterials Technology Pte. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/11/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today